Selective use of calcium channel blockers to treat high-risk hypertensive patients

Pharmacoepidemiology and Drug Safety

Volumn 9, Issue 1, 2000, Pages 1-9

  Huse, Daniel M ^a   Roht, Lewis H ^b   Hartz, Stuart C ^a  

^a Innovative Clinical Solutions Ltd   (United States)

^b SANOFI   (France)

Author keywords

Attitudes and practice; Calcium channel blockers; Confounding factors; Hypertension; Knowledge; Risk factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANGINA PECTORIS; ARTICLE; ATTITUDE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DRUG USE; FAMILY HISTORY; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HIGH RISK POPULATION; HOSPITAL PHYSICIAN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; UNITED STATES;

EID: 0034098220     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(200001/02)9:1<1::AID-PDS470>3.0.CO;2-A     Document Type: Article

References (16)

1. Espeland MA, Kumanyika S, Kostis JB, et al. Antihypertensive medication use among recruits for the Trial of Nonpharmacologic Interventions in the Elderly (TONE). J Am Geriatr Soc 1996; 44: 1183-1189.
2. Leader SG, Mallick R, Briggs NC. Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers. Am J Med 1997; 102: 150-157.
3. Manolio TA, Cutler JA, Furberg CD, et al. Trends in pharmacologic management of hypertension in the US. Arch Intern Med 1995; 155: 829-837.
4. Pahor M, Guralnik JM, Furberg CD, et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347: 1061-1065.
5. Pahor M, Guralnik JM, Salive ME, et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9: 695-699.
6. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
7. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997; 349: 594-598.
8. Jick H, Derby LF, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996; 16: 321-326.
9. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA 1995; 274: 654-655.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-183.
11. Anonymous. 1996 Physicians' Desk Reference. Medical Economics Company, Inc.: Montvale, NJ, 1996.
12. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
13. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. John Wiley & Sons, Inc.: New York, 1991.
14. Leader S, Mallick R, Roht LH. Using medication history to measure indication bias in observational studies of antihypertensive therapy risks. Am J Hyperten 1998; 11: 263A.
15. Aursnes I, Litleskare I, Froyland H, Abdelnoor M. Association between various drugs used for hypertension and risk of acute myocardial infarction. Blood Press 1995; 4: 157-163.
16. Jick H, Vasilakis C, Derby LE. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension. Epidemiology 1997; 8: 446-448.